Currently, there are no guidelines for chemotherapy administration in hepatitis C virus-positive patients with breast cancer. This article addresses the knowledge gap, comparing breast cancer patients with and without concurrent hepatitis C virus to determine level of tolerance to treatment.
This report underscores the importance of genetic analysis of serial biopsies to capture the dynamic therapeutic vulnerabilities within a patient’s tumor, while providing a perspective on the complexity of ALK tyrosine kinase inhibitor treatment sequencing.
This article describes a patient with high-grade pancreatic neuroendocrine tumor and BRCA1 germline mutation who had a significant response to Lutetium-177-Dotatate and summarizes the current state of clinical management of high-grade neuroendocrine tumors.
Cancer patients have an increased risk of contracting COVID-19. This article addresses the challenges associated with managing cancer patients during the COVID-19 infection pandemic and suggests some practical approaches.